This is an external website. ITN is not responsible for any content on the third party website.
AngioDynamics to Acquire RadiaDyne to Expand Oncology Portfolio
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes.